Danaos Corporation (NYSE:DAC) Analysts Are Pretty Bullish On The Stock After Recent Results

Last week, you might have seen that Danaos Corporation (NYSE:DAC) released its full-year result to the market. The early response was not positive, with shares down 2.7% to US$72.04 in the past week. Results were roughly in line with estimates, with revenues of US$974m and statutory earnings per share of US$28.95. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

See our latest analysis for Danaos

earnings-and-revenue-growth
NYSE:DAC Earnings and Revenue Growth February 16th 2024

Taking into account the latest results, the current consensus from Danaos' three analysts is for revenues of US$1.01b in 2024. This would reflect a credible 3.6% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to increase 2.8% to US$30.46. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$983.6m and earnings per share (EPS) of US$28.90 in 2024. So there seems to have been a moderate uplift in sentiment following the latest results, given the upgrades to both revenue and earnings per share forecasts for next year.

With these upgrades, we're not surprised to see that the analysts have lifted their price target 5.4% to US$78.67per share. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Danaos at US$90.00 per share, while the most bearish prices it at US$67.00. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It's pretty clear that there is an expectation that Danaos' revenue growth will slow down substantially, with revenues to the end of 2024 expected to display 3.6% growth on an annualised basis. This is compared to a historical growth rate of 21% over the past five years. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 0.4% per year. Even after the forecast slowdown in growth, it seems obvious that Danaos is also expected to grow faster than the wider industry.

Advertisement

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Danaos' earnings potential next year. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

With that in mind, we wouldn't be too quick to come to a conclusion on Danaos. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Danaos analysts - going out to 2025, and you can see them free on our platform here.

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Danaos (at least 1 which is a bit unpleasant) , and understanding them should be part of your investment process.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NYSE:DAC

Danaos

Through its subsidiaries, owns and operates containerships and drybulk vessels in Australia, Europe, and the United States.

Flawless balance sheet and undervalued.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7065.0% undervalued
41 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9636.2% undervalued
45 users have followed this narrative
8 users have commented on this narrative
14 users have liked this narrative
NI
niteco
AVGO logo
niteco on Broadcom ·

A Capital Allocation Favorite with Structural Importance

Fair Value:US$651.0541.3% undervalued
43 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
TO
Tokyo
OKTA logo
Tokyo on Okta ·

Good foundation, but now it's all about the next steps

Fair Value:US$15123.0% undervalued
90 users have followed this narrative
7 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

DC
DOCS logo
Dc12 on Doximity ·

High physician usership and impressive AI tools

Fair Value:US$33.740.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
Rog
CTT logo
Rog on CTT - Correios De Portugal ·

Why CTT benefits in multiple ways right now

Fair Value:€6.6710.2% undervalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ES
HSY logo
Esteban on Hershey ·

Hershey - fortress brand-and-scale position in U.S. confectionery: protects the downside far better than it compounds the upside

Fair Value:US$85.86111.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7446.4% undervalued
65 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9723.5% undervalued
58 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1931.2% undervalued
49 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative